Baptist Health Hardin, Elizabethtown
Baptist Health Lexington, Lexington
University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington

Renkami dalyviai2/3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT06712316

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Kentucky/Markey Cancer Center, Lexington

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT06287775

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

CHI Saint Joseph Cancer Center - East, Lexington
University of Kentucky Chandler Medical Center, Lexington

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT06119581

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Baptist Health Hardin Cancer Center, Elizabethtown

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT06712355

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

University of Kentucky ( Site 0019), Lexington

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT06731907

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Louisville

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-03 · NCT05433142

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Norton Cancer Institute, Louisville

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-29 · NCT04198766

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

James Graham Brown Cancer Center (Melanoma/NSCLC), Louisville

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-16 · NCT06060613

EXoPERT EMERALD Clinical Study

Lexington VA Healthcare System, Lexington
KCTL, Louisville

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai

Amžius 45 ir vyresni · Visoms lytims · Atnaujinta 2026-07-01 · NCT07186296

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

University of Louisville, Louisville

Renkami dalyviai2 fazė

Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-06-26 · NCT04614103

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

University of Louisville, Louisville

Renkami dalyviai1/2 fazė

Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-06-11 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-03 · NCT05642572

Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment

University of Kentucky, Lexington

Renkami dalyviai

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-08 · NCT06047301

A Study of ZW251 in Participants With Advanced Solid Tumors

Norton Cancer Institute, Louisville

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-07 · NCT07164313

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

Renkami dalyviai2 fazė

18 Minutes · Visoms lytims · Atnaujinta 2026-05-05 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

University of Kentucky/Markey Cancer Center, Lexington

Renkami dalyviai2/3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-05 · NCT06616584

Precision Lung Cancer Survivorship Care Intervention

Markey Cancer Center, Lexington

Renkami dalyviai

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-23 · NCT05857995

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

University of Kentucky Markey Cancer Center, Lexington

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-13 · NCT06778863

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Baptist Corbin, Corbin
Baptist Hardin, Elizabethtown
Baptist Lexington, Lexington

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai

Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-01-20 · NCT05366881

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Lexington VA Health Care System, Lexington
Robley Rex VA Medical Center, Louisville

Renkami dalyviaiStebimasis tyrimas

Amžius nuo 29 iki 85 · Visoms lytims · Atnaujinta 2024-11-13 · NCT06426628

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.